{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T12:57:05Z","timestamp":1787317025282,"version":"build-2736575974"},"reference-count":68,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Surgeon"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.surge.2020.09.001","type":"journal-article","created":{"date-parts":[[2020,10,23]],"date-time":"2020-10-23T12:59:02Z","timestamp":1603457942000},"page":"e153-e167","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Does perioperative biological therapy increase 30-day post-operative complication rates in inflammatory bowel disease patients undergoing intra-abdominal surgery? A systematic review"],"prefix":"10.1016","volume":"19","author":[{"given":"Laura Wilhelmina","family":"Byrne","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damian","family":"McKay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.surge.2020.09.001_bib1","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1136\/gut.2010.224154","article-title":"Guidelines for the management of inflammatory bowel disease in adults","volume":"60","author":"Mowat","year":"2011","journal-title":"Gut"},{"key":"10.1016\/j.surge.2020.09.001_bib2","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1136\/pgmj.44.515.684","article-title":"Ulcerative colitis: definition, historical background, aetiology, diagnosis, naturel history and local complications","volume":"44","author":"De Dombal","year":"1968","journal-title":"Postgrad Med"},{"issue":"1","key":"10.1016\/j.surge.2020.09.001_bib3","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1093\/ecco-jcc\/jjw168","article-title":"European evidence-based consensus on the diagnosis and management of Crohn's disease 2016: Part 1: diagnosis and medical management","volume":"11","author":"Gomoll\u00f3n","year":"2016","journal-title":"J Crohns Colitis"},{"issue":"19 Suppl A","key":"10.1016\/j.surge.2020.09.001_bib4","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1155\/2005\/269076","article-title":"Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology","author":"Silverberg","year":"2005","journal-title":"Can J Gastroenterol"},{"issue":"15","key":"10.1016\/j.surge.2020.09.001_bib5","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.3748\/wjg.v18.i15.1708","article-title":"Etiology of inflammatory bowel disease: a unified hypothesis","volume":"18","author":"Qin","year":"2012","journal-title":"World J Gastroenterol"},{"issue":"1","key":"10.1016\/j.surge.2020.09.001_bib6","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3748\/wjg.v20.i1.91","article-title":"Inflammatory bowel disease: Pathogenesis","volume":"20","author":"Zhang","year":"2014","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.surge.2020.09.001_bib7","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1053\/j.gastro.2007.11.059","article-title":"Microbial influences in inflammatory bowel diseases","volume":"134","author":"Sartor","year":"2008","journal-title":"Gastroenterology"},{"issue":"Suppl 3","key":"10.1016\/j.surge.2020.09.001_bib8","doi-asserted-by":"crossref","first-page":"s1","DOI":"10.1136\/gutjnl-2019-318484","article-title":"British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults","volume":"68","author":"Lamb","year":"2019","journal-title":"Gut"},{"issue":"8","key":"10.1016\/j.surge.2020.09.001_bib9","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.3390\/ijms19082244","article-title":"Anti-TNF therapy in Crohn's disease","volume":"19","author":"Adegbola","year":"2018","journal-title":"Int J Mol Sci"},{"issue":"5","key":"10.1016\/j.surge.2020.09.001_bib10","doi-asserted-by":"crossref","first-page":"397","DOI":"10.2165\/00063030-199810050-00006","article-title":"Infliximab","volume":"10","author":"Onrust","year":"1998","journal-title":"BioDrugs"},{"issue":"4","key":"10.1016\/j.surge.2020.09.001_bib11","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1097\/00054725-199811000-00014","article-title":"Infliximab approved for use in Crohn\u02bcs disease: a report on the FDA GI advisory committee conference","volume":"4","author":"Kornbluth","year":"1998","journal-title":"Inflamm Bowel Dis"},{"issue":"2","key":"10.1016\/j.surge.2020.09.001_bib12","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.jcol.2017.01.001","article-title":"Postoperative mortality in inflammatory bowel disease patients","volume":"37","author":"Ropelato","year":"2017","journal-title":"J Coloproctology"},{"issue":"2","key":"10.1016\/j.surge.2020.09.001_bib13","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/DCR.0b013e31819ad456","article-title":"Severity of inflammation as a predictor of colectomy in patients with chronic ulcerative colitis","volume":"52","author":"Hefti","year":"2009","journal-title":"Dis Colon Rectum"},{"issue":"2","key":"10.1016\/j.surge.2020.09.001_bib14","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1093\/ecco-jcc\/jjy113","article-title":"ECCO-ESGAR Guideline for Diagnostic Assessment in IBD Part 1: initial diagnosis, monitoring of known IBD, detection of complications","volume":"13","author":"Maaser","year":"2018","journal-title":"J Crohns Colitis"},{"issue":"17","key":"10.1016\/j.surge.2020.09.001_bib15","doi-asserted-by":"crossref","first-page":"4839","DOI":"10.3748\/wjg.v20.i17.4839","article-title":"Anti-TNF alpha in the treatment of ulcerative colitis: a valid approach for organ-sparing or an expensive option to delay surgery?","volume":"20","author":"Rizzo","year":"2014","journal-title":"World J Gastroenterol"},{"issue":"29","key":"10.1016\/j.surge.2020.09.001_bib16","doi-asserted-by":"crossref","first-page":"3828","DOI":"10.3748\/wjg.v18.i29.3828","article-title":"Surgery for Crohn's disease in the era of biologicals: a reduced need or delayed verdict?","volume":"18","author":"de Buck van Overstraeten","year":"2012","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.surge.2020.09.001_bib17","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1097\/00000658-199002000-00002","article-title":"Tumor necrosis factor and wound healing","volume":"211","author":"Mooney","year":"1990","journal-title":"Ann Surg"},{"issue":"1","key":"10.1016\/j.surge.2020.09.001_bib18","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jss.2014.07.022","article-title":"Infliximab treatment reduces tensile strength in intestinal anastomosis","volume":"193","author":"Jensen","year":"2015","journal-title":"J Surg Res"},{"issue":"4","key":"10.1016\/j.surge.2020.09.001_bib19","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1007\/s00068-003-1284-6","article-title":"In\u00a0vivo effect of tumor necrosis factor Alpha on wound angiogenesis and epithelialization","volume":"29","author":"Frank","year":"2003","journal-title":"Eur J Trauma"},{"key":"10.1016\/j.surge.2020.09.001_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2018\/6941368","article-title":"Roles of macrophage subtypes in bowel anastomotic healing and anastomotic leakage","volume":"2018","author":"Shi","year":"2018","journal-title":"J Immunol Res"},{"issue":"2","key":"10.1016\/j.surge.2020.09.001_bib21","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1093\/ibd\/izx036","article-title":"Postoperative morbidity risks following ileocolic resection for Crohn's disease treated with anti-TNF alpha therapy: a retrospective study of 360 patients","volume":"24","author":"Jouvin","year":"2018","journal-title":"Inflamm Bowel Dis"},{"issue":"3","key":"10.1016\/j.surge.2020.09.001_bib22","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1097\/SLA.0000000000000757","article-title":"The impact of preoperative serum anti-TNF\u03b1 therapy levels on early postoperative outcomes in inflammatory bowel disease surgery","volume":"261","author":"Lau","year":"2015","journal-title":"Ann Surg"},{"issue":"4","key":"10.1016\/j.surge.2020.09.001_bib23","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/ajg.2012.464","article-title":"Anti-Tumor necrosis factor therapy is associated with infections after abdominal surgery in crohn's disease patients","volume":"108","author":"Syed","year":"2013","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"10.1016\/j.surge.2020.09.001_bib24","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.crohns.2012.03.013","article-title":"Previous infliximab therapy and postoperative complications after proctocolectomy with ileum pouch anal anastomosis","volume":"7","author":"Eshuis","year":"2013","journal-title":"J Crohns Colitis"},{"issue":"10","key":"10.1016\/j.surge.2020.09.001_bib25","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1007\/s11605-008-0646-0","article-title":"Use of infliximab within 3 Months of ileocolonic resection is associated with adverse postoperative outcomes in Crohn's patients","volume":"12","author":"Appau","year":"2008","journal-title":"J Gastrointest Surg"},{"issue":"8","key":"10.1016\/j.surge.2020.09.001_bib26","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1007\/s10350-008-9364-7","article-title":"Infliximab in ulcerative colitis is associated with an increased risk of postoperative complications after restorative proctocolectomy","volume":"51","author":"Mor","year":"2008","journal-title":"Dis Colon Rectum"},{"issue":"5","key":"10.1016\/j.surge.2020.09.001_bib27","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/j.jamcollsurg.2006.12.044","article-title":"Effect of infliximab on short-term complications in patients undergoing operation for chronic ulcerative colitis","volume":"204","author":"Selvasekar","year":"2007","journal-title":"J Am Coll Surg"},{"issue":"10","key":"10.1016\/j.surge.2020.09.001_bib28","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1097\/MIB.0000000000000919","article-title":"Preoperative anti\u2013tumor necrosis factor therapy in patients with ulcerative colitis is not associated with an increased risk of infectious and noninfectious complications after ileal pouch\u2013anal anastomosis","volume":"22","author":"Zittan","year":"2016","journal-title":"Inflamm Bowel Dis"},{"issue":"9","key":"10.1016\/j.surge.2020.09.001_bib29","doi-asserted-by":"crossref","first-page":"2602","DOI":"10.1007\/s10620-016-4171-9","article-title":"Timing of last preoperative dose of infliximab does not increase postoperative complications in inflammatory bowel disease patients","volume":"61","author":"Alsaleh","year":"2016","journal-title":"Dig Dis Sci"},{"issue":"5","key":"10.1016\/j.surge.2020.09.001_bib30","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1002\/bjs.9439","article-title":"Complications in surgery for Crohn's disease after preoperative antitumour necrosis factor therapy","volume":"101","author":"Myrelid","year":"2014","journal-title":"Br J Surg"},{"issue":"5","key":"10.1016\/j.surge.2020.09.001_bib31","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1111\/codi.13937","article-title":"Anti-TNF therapy is not associated with an increased risk of post-colectomy complications, a population-based study","volume":"20","author":"Ward","year":"2018","journal-title":"Colorectal Dis"},{"issue":"2","key":"10.1016\/j.surge.2020.09.001_bib32","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1007\/s10620-016-4400-2","article-title":"Tumor necrosis factor Alpha inhibitors did not influence postoperative morbidity after elective surgical resections in Crohn's disease","volume":"62","author":"Kotze","year":"2016","journal-title":"Dig Dis Sci"},{"issue":"3","key":"10.1016\/j.surge.2020.09.001_bib33","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1159\/000437362","article-title":"Does pre-operative multiple immunosuppressive therapy associate with surgical site infection in surgery for ulcerative colitis?","volume":"92","author":"Uchino","year":"2015","journal-title":"Digestion"},{"issue":"7","key":"10.1016\/j.surge.2020.09.001_bib34","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1002\/ibd.20863","article-title":"Corticosteroids but not infliximab increase short-term postoperative infectious complications in patients with ulcerative colitis","volume":"15","author":"Ferrante","year":"2009","journal-title":"Inflamm Bowel Dis"},{"issue":"4","key":"10.1016\/j.surge.2020.09.001_bib35","first-page":"244","article-title":"Safety and positioning of vedolizumab in patients with inflammatory bowel disease","volume":"14","author":"Feagan","year":"2018","journal-title":"J Gastroenterol Hepatol"},{"issue":"5","key":"10.1016\/j.surge.2020.09.001_bib36","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1093\/ecco-jcc\/jjy022","article-title":"Systematic review and meta-analysis: preoperative vedolizumab treatment and postoperative complications in patients with inflammatory bowel disease","volume":"12","author":"Law","year":"2018","journal-title":"J Crohns Colitis"},{"issue":"7","key":"10.1016\/j.surge.2020.09.001_bib37","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1016\/j.jpedsurg.2017.12.001","article-title":"Postoperative complications of pediatric patients with inflammatory bowel disease treated with vedolizumab","volume":"53","author":"Zimmerman","year":"2018","journal-title":"J Pediatr Surg"},{"issue":"4","key":"10.1016\/j.surge.2020.09.001_bib38","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1093\/ibd\/izx076","article-title":"Postoperative outcomes in vedolizumab-treated patients undergoing major abdominal operations for inflammatory bowel disease: retrospective multicenter cohort study","volume":"24","author":"Lightner","year":"2018","journal-title":"Inflamm Bowel Dis"},{"issue":"3","key":"10.1016\/j.surge.2020.09.001_bib39","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/s41575-018-0084-8","article-title":"IL-12, IL-23 and IL-17 in IBD: immunobiology and therapeutic targeting","volume":"16","author":"Moschen","year":"2018","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.surge.2020.09.001_bib40","doi-asserted-by":"crossref","first-page":"b2535","DOI":"10.1136\/bmj.b2535","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"339","author":"Moher","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.surge.2020.09.001_bib41","series-title":"Prisma-statement.org","year":"2019"},{"issue":"2","key":"10.1016\/j.surge.2020.09.001_bib42","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/ijcp.12767","article-title":"How to use the medical subject headings (Me SH )","volume":"70","author":"Baumann","year":"2016","journal-title":"Int J Clin Pract"},{"issue":"3","key":"10.1016\/j.surge.2020.09.001_bib43","doi-asserted-by":"crossref","first-page":"326","DOI":"10.5114\/wiitm.2018.76179","article-title":"Postoperative complications are associated with worse survival after laparoscopic surgery for non-metastatic colorectal cancer \u2013 interim analysis of 3-year overall survival","volume":"13","author":"Nowakowski","year":"2018","journal-title":"Videosurg Other Miniinvasive Tech"},{"issue":"7","key":"10.1016\/j.surge.2020.09.001_bib44","doi-asserted-by":"crossref","first-page":"3225","DOI":"10.1007\/s00464-018-6040-4","article-title":"Changes in plasma albumin levels in early detection of infectious complications after laparoscopic colorectal cancer surgery with ERAS protocol","volume":"32","author":"Wierdak","year":"2018","journal-title":"Surg Endosc"},{"key":"10.1016\/j.surge.2020.09.001_bib45","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/B978-1-4377-0603-1.00040-5","article-title":"Biologic therapies infliximab, adalimumab, etanercept, daclizumab, and others","author":"Yeh","year":"2010","journal-title":"Ret Pharmacother"},{"key":"10.1016\/j.surge.2020.09.001_bib46","series-title":"Classification of Intervention","author":"Alleway","year":"2019"},{"issue":"3","key":"10.1016\/j.surge.2020.09.001_bib47","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1111\/bcp.12267","article-title":"Paediatric pharmacokinetics: key considerations","volume":"79","author":"Batchelor","year":"2015","journal-title":"Br J Clin Pharmacol"},{"issue":"11","key":"10.1016\/j.surge.2020.09.001_bib48","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1097\/MIB.0000000000000218","article-title":"Tumor necrosis factor-alpha antagonists twenty years later","volume":"20","author":"Akobeng","year":"2014","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.surge.2020.09.001_bib49","series-title":"Ottawa Hospital Research Institute","author":"Wells","year":"2019"},{"key":"10.1016\/j.surge.2020.09.001_bib50","series-title":"Data extraction and assessment tool [internet]","year":"2019"},{"key":"10.1016\/j.surge.2020.09.001_bib51","series-title":"Cochrane handbook for systematic reviews of interventions","year":"2011"},{"issue":"11","key":"10.1016\/j.surge.2020.09.001_bib52","first-page":"1243","article-title":"Operative strategy modifies risk of pouch-related outcomes in patients with ulcerative colitis on preoperative anti-tumor necrosis factor-\u03b1 therapy: Diseases of the colon & rectum","volume":"56","author":"Gu","year":"2013"},{"issue":"3","key":"10.1016\/j.surge.2020.09.001_bib53","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/codi.13929","article-title":"Adalimumab and postoperative complications of elective intestinal resections in Crohn's disease: a propensity score case-matched study","volume":"20","author":"Kotze","year":"2018","journal-title":"Colorectal Dis"},{"issue":"9","key":"10.1016\/j.surge.2020.09.001_bib54","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1007\/s11605-016-3194-z","article-title":"Effect of anti-TNF agents on postoperative outcomes in inflammatory bowel disease patients: a single institution experience","volume":"20","author":"Shwaartz","year":"2016","journal-title":"J Gastrointest Surg"},{"issue":"4","key":"10.1016\/j.surge.2020.09.001_bib55","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1093\/ecco-jcc\/jjx163","article-title":"Postoperative outcomes in ustekinumab-treated patients undergoing abdominal operations for Crohn's disease","volume":"12","author":"Lightner","year":"2018","journal-title":"J Crohns Colitis"},{"issue":"5","key":"10.1016\/j.surge.2020.09.001_bib56","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1111\/apt.14459","article-title":"\u201cPostoperative outcomes in vedolizumab-treated Crohn's disease patients undergoing major abdominal operations","volume":"47","author":"Lightner","year":"2018","journal-title":"Aliment Pharmacol Ther"},{"issue":"2","key":"10.1016\/j.surge.2020.09.001_bib57","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1093\/ecco-jcc\/jjw147","article-title":"Postoperative outcomes in vedolizumab-treated patients undergoing abdominal operations for inflammatory bowel disease","volume":"11","author":"Lightner","year":"2017","journal-title":"J Crohns Colitis"},{"issue":"1","key":"10.1016\/j.surge.2020.09.001_bib58","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/01.MIB.0000437497.07181.05","article-title":"Rescue therapy with cyclosporine or infliximab is not associated with an increased risk for postoperative complications in patients hospitalized for severe steroid-refractory ulcerative colitis","volume":"20","author":"Nelson","year":"2014","journal-title":"Inflamm Bowel Dis"},{"issue":"12","key":"10.1016\/j.surge.2020.09.001_bib59","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1097\/MIB.0000000000001248","article-title":"\u201cSurgical outcomes in vedolizumab-treated patients with ulcerative colitis:\u201d inflammatory","volume":"23","author":"Lightner","year":"2017","journal-title":"Bowel Diseases"},{"issue":"1","key":"10.1016\/j.surge.2020.09.001_bib60","first-page":"1","article-title":"Pediatric perioperative stress responses and anesthesia","volume":"2","author":"Yuki","year":"2017","journal-title":"Transl Perioper & Pain Med"},{"issue":"3","key":"10.1016\/j.surge.2020.09.001_bib61","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1136\/gutjnl-2011-301495","article-title":"Preoperative biological therapy and short-term outcomes of abdominal surgery in patients with inflammatory bowel disease","volume":"62","author":"Waterman","year":"2012","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.surge.2020.09.001_bib62","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1080\/08941939.2016.1274346","article-title":"The trainee effect on early postoperative surgical outcomes: reflects the effect of resident involvement or hospital capacity to overcome complications?","volume":"31","author":"Can","year":"2017","journal-title":"J Invest Surg"},{"issue":"6","key":"10.1016\/j.surge.2020.09.001_bib63","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1136\/gut.2005.082909","article-title":"The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications","volume":"55","author":"Satsangi","year":"2006","journal-title":"Gut"},{"issue":"2","key":"10.1016\/j.surge.2020.09.001_bib64","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/SLA.0b013e3181b13ca2","article-title":"The clavien-dindo classification of surgical complications","volume":"250","author":"Clavien","year":"2009","journal-title":"Ann Surg"},{"issue":"3","key":"10.1016\/j.surge.2020.09.001_bib65","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1093\/gastro\/gow046","article-title":"Perioperative use of immunosuppressive medications in patients with Crohn's disease in the new \"biological era","volume":"5","author":"Lightner","year":"2017","journal-title":"Gastroenterol Rep"},{"key":"10.1016\/j.surge.2020.09.001_bib66","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.5114\/aoms.2011.26612","article-title":"A systematic review and meta-analysis of the effects of infliximab on the rate of colectomy and post-operative complications in patients with inflammatory bowel disease","volume":"6","author":"Ehteshami-Afshar","year":"2011","journal-title":"Arch Med Sci"},{"issue":"7","key":"10.1016\/j.surge.2020.09.001_bib67","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1097\/MEG.0b013e32833036d9","volume":"22","author":"Szamosi","year":"2010","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"11","key":"10.1016\/j.surge.2020.09.001_bib68","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/j.crohns.2013.01.019","article-title":"The risks of post-operative complications following pre-operative infliximab therapy for Crohn's disease in patients undergoing abdominal surgery: a systematic review and meta-analysis","volume":"7","author":"Rosenfeld","year":"2013","journal-title":"J Crohns Colitis"}],"container-title":["The Surgeon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1479666X20301451?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1479666X20301451?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T14:18:53Z","timestamp":1761488333000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1479666X20301451"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":68,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["S1479666X20301451"],"URL":"https:\/\/doi.org\/10.1016\/j.surge.2020.09.001","relation":{},"ISSN":["1479-666X"],"issn-type":[{"value":"1479-666X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Does perioperative biological therapy increase 30-day post-operative complication rates in inflammatory bowel disease patients undergoing intra-abdominal surgery? A systematic review","name":"articletitle","label":"Article Title"},{"value":"The Surgeon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.surge.2020.09.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2020 Published by Elsevier Ltd on behalf of Royal College of Surgeons of Edinburgh (Scottish charity number SC005317) and Royal College of Surgeons in Ireland. All rights reserved.","name":"copyright","label":"Copyright"}]}}